Executive Director, Channel Distribution Strategy jobs in United States
cer-icon
Apply on Employer Site
company-logo

Skyhawk Therapeutics · 5 days ago

Executive Director, Channel Distribution Strategy

Skyhawk Therapeutics is committed to discovering and developing small molecule therapeutics that modify RNA expression. The Executive Director, Channel Distribution Strategy will lead the design and implementation of channel distribution strategies across Skyhawk’s portfolio in North America, ensuring maximum access and efficiency in distribution while navigating complex regulations and policies.

BiotechnologyTherapeutics

Responsibilities

Serve as subject matter expert on evolving supply chain and distribution related laws, channel models, and strategic channel partner business models and capabilities
Maintain a deep understanding of the Hospital, Specialty & Retail pharmacy channels; understand pharmacy and hospital capabilities and the competitive marketplace to ensure Skyhawk maintains an industry leading approach to patient support in specialty channels
Lead a team in designing scalable, innovative distribution strategies to maximize patient access and achieve corporate goals while considering financial impact, patient/ customer experience and strategic alliances
Support recommendation with strong analytics and consideration of channel economics, active and pending policy (e.g. serialization, importation, state and federal pricing policy, etc.), reimbursement, setting of care, financial implications and patient access dynamics
Collaborate with and ensure alignment across key stakeholders on channel distribution strategy development; Deliver recommendations to Senior Leadership and relevant, internal governing bodies and strategic teams
Explore and develop direct to consumer distribution capabilities, market expertise and differentiations for Skyhawk’s portfolio programs
Partner with commercial operation, market access and other teams to generate insights and inform commercialization planning, including forecasting, gross-to-net and operational build considerations

Qualification

Pharmaceutical distribution expertiseStrategic planningChannel distribution strategyCross-functional leadershipData analysisPatient access dynamicsReimbursement knowledgeLeadership experienceManage prioritiesCommunicationInterpersonal skills

Required

Bachelor's degree in relevant field
Deep industry experience (15+ years) in trade and distribution in pharmaceutical or biotechnology companies
Expert knowledge of drug distribution channels including orphan drugs, 3PL, specialty distribution, specialty pharmacy, and Direct to Consumer channels
Proven track record of meeting or exceeding objectives & goals, both as an individual and as part of a team
Proven ability to develop and lead strategic initiatives and projects both internally and with external consultant support
Relevant experience with distribution networks, new product launches, trade processes, and understanding of pharmaceutical supply chain
Demonstrated understanding of the US commercial and government healthcare and reimbursement environment, including product and fund flow, patient support and government programs
Excellent communication skills with experience presenting to customers and internal leadership
Demonstrated ability to successfully navigate cross-functional teams, influencing without direct authority, with the interpersonal skills to foster collaboration and succeed in a highly matrixed environment
Ability to perform in a fast-paced environment, manage multiple priorities simultaneously, and work effectively across cross-functional teams

Preferred

Master's Degree
Previous channel distribution experience with rare disease and small molecule
Previous solid leadership experience in building distribution strategies for orphan drug launch

Company

Skyhawk Therapeutics

twittertwittertwitter
company-logo
Skyhawk Therapeutics is a provvider of small molecule therapeutics designed to offer therapies that correct RNA expression.

Funding

Current Stage
Growth Stage
Total Funding
$181.2M
Key Investors
FidelityGood Growth Capital
2021-09-14Series Unknown· $133M
2019-01-01Series A
2018-06-15Series A· $40M

Leadership Team

leader-logo
Bill Haney
Co-founder & CEO Skyhawk Therapeutics
linkedin
Company data provided by crunchbase